Allison N LaHood

5PUBLICATIONS
40CO-AUTHORS
PharmacogenomicsMedical bacteriologyBehavioural epidemiologyPharmacology and pharmaceutical sciences not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 24, 2026
Clofazimine pharmacokinetics in novel rifampicin-resistant tuberculosis regimens: an analysis of the endTB and endTB-Q trials.

|Jul 01, 2026
Low Post-Treatment Recurrence After a Shortened All-oral Regimen for Pulmonary Rifampicin- or Multidrug-Resistant Tuberculosis in Individuals without Prior Second-Line Drug Exposure in Kazakhstan.

|Jun 12, 2026
Comparison of three linezolid management strategies for peripheral neuropathy in multidrug- or rifampicin-resistant tuberculosis treatment: a target trial emulation.

|Feb 02, 2026
Estimating the effect of hepatitis C infection on multidrug-resistant tuberculosis treatment outcomes under hypothetical interventions on regimen composition and adherence.

Allison LaHood, James Robins, Helen R Stagg

|Jul 25, 2022
Comparing timelines and evidence available to support new TB, HIV, and HCV drug approvals: The same, only different.

Allison LaHood, Rifat Rahman, Lindsay McKenna

Pageof 1

Frequent Collaborators

3 joint publications

Carole D Mitnick

3 joint publications

Molly F Franke

2 joint publications

Letizia Trevisi

2 joint publications

Lorenzo Guglielmetti